A solar-powered airplane finished crossing the United States on Saturday, landing in New York City after flying over the Statue of Liberty during its historic bid to circle the globe, the project team said. The spindly, single-seat experimental aircraft, dubbed Solar Impulse 2, arrived at New York's John F. Kennedy International Airport at about 4 a.m. local time after it took off about five hours beforehand at Lehigh Valley International Airport in Pennsylvania, the team reported on the airplane's website. Such a pleasure to land in New York! For the 14th time we celebrate sustainability," said the project's co-founder Andre Borschberg on Twitter after flying over the city and the Statue of Liberty during the 14th leg of the trip around the globe. The Swiss team flying the aircraft in a campaign to build support for clean energy technologies hopes eventually to complete its circumnavigation in Abu Dhabi, where the journey began in March 2015. The solar cr...
A new probe that sticks to blood clots so they can be seen in a PET scan has proved successful in rats - and will be tested in humans later this year, according to researchers in the US. They say the technique can scan the entire body and pinpoint the location of large and small blood clots.
This would offer an advantage over present methods, which concentrate on individual parts of the body. In the rat study, blood clots "lit up" brightly in a whole-body PET scan. Speaking at a meeting of the American Chemical Society in Boston, the scientists said that if human trials were similarly successful, the technique could be available within a few years.
"Our idea is that from a single injection, the probe will travel through the body and find blood clots anywhere." He and his colleagues made and tested 15 different probes before they found one that worked really well. It consists of a small peptide molecule that binds to the clot protein fibrin, coupled to a radioactive "label" that can be detected in the scanner. The results in rats, published this week, were particularly promising because of how clearly the blood clots stood out.
"There's very little background signal here - we've got very high conspicuity," Dr Caravan said. "We're hoping to start studies in humans later this year. And then it will take some years to prove to the regulatory agencies that this is indeed effective and accurate. That's the next stage of the journey."Prof Jeremy Pearson is the Associate Medical Director (Research) at the British Heart Foundation. He said the results were preliminary, but was impressed by how well-suited the probe was to the task. "Clearly, it doesn't work for emergencies. But for people who have had a stroke and you want to find the thrombus a day or two later, it could be very useful.
"The disadvantage of any PET scanning technology is that you're exposing the patient to extra radiation. But there are plenty of examples now... where PET imaging is a useful adjunct - the additional radiation dose is not significant and it's outweighed by the benefits you might get."
He suggested that the scan could prove particularly valuable in searching for smaller clots.
Comments
Post a Comment